TGA Approval

ABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vial (334814)

ARTG ID

334814

ARTG Name

ABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vial

Sponsor

Maxx Pharma Pty Ltd

ARTG Date

September 6, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Maxx Pharma Pty Ltd

https://medical-cdn.nocode.com/drug_tga/957c2c2864cbbe46ddc45aebb71d2f23.pdf

https://medical-cdn.nocode.com/drug_tga/e4c5fc4260647cc22c3dc5de567f6dd5.pdf

Ingredient Name

Bevacizumab

Empowering clinical research with data-driven insights and AI-powered tools.

ABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vial (334814) - TGA 批准文号 | MedPath